Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-19

Clinical Trial Update: Evaluation of the Express Plus Range [NA]

View source ↗

Summary

A completed clinical trial evaluated Vitaflo's Express Plus Range for multiple metabolic disorders including phenylketonuria, homocystinuria, maple syrup urine …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Express Plus Range

Snippet

Sponsor: Vitaflo International, Ltd | Conditions: Phenylketonurias, PKU | NA | Status: COMPLETED